CDXS - コデクシス (Codexis Inc.) コデクシス

 CDXSのチャート


 CDXSの企業情報

symbol CDXS
会社名 Codexis Inc (コデクシス)
分野(sector) Basic Industries   素材
産業(industry) Major Chemicals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 コデクシス(Codexis Inc.)はタンパク質エンジニアリング会社である。同社は、医薬品およびファインケミカルの商業用製造のための生体触媒の開発に従事している。同社はパフォーマンス酵素及び新規の生物療法剤2つの事業を運営する。同社は、小規模から商業的な量までの酵素最適化サービスを提供し、また生体触媒製品を開発する。また、活性医薬成分、ファインケミカル、食品成分の製造プロセスの開発に従事する。同社のCodeEvolverは、タンパク質工学の技術プラットフォームであり、医薬品市場における製品である。同社は、食品および食品原料、動物飼料、香料、香料及び農薬を含む各産業にサービスを提供する。   コデクシスは米国のバイオテクノロジ―企業。医薬品及び精製化学製品市場のための生体触媒を開発、生産。製薬会社のほか、食品、動物飼料、ポリマ―、香味及び香料、農薬などの製造会社に、生体触媒である酵素を提供する。同社は2002年に設立し、カリフォルニア州に本社を置く。   
本社所在地 200 Penobscot Drive Redwood City CA 94063 USA
代表者氏名 Bernard J. Kelley バーナード・J.・ケリー
代表者役職名 Chairman of the Board 取締役会会長
電話番号 +1 650-421-8100
設立年月日 37257
市場名 NASDAQ National Market System
ipoyear 2010年
従業員数 116人
url www.codexis.com
nasdaq_url https://www.nasdaq.com/symbol/cdxs
adr_tso
EBITDA EBITDA(百万ドル) -16.71000
終値(lastsale) 16.5
時価総額(marketcap) 882953791.5
時価総額 時価総額(百万ドル) 917.73680
売上高 売上高(百万ドル) 59.28700
企業価値(EV) 企業価値(EV)(百万ドル) 864.29880
当期純利益 当期純利益(百万ドル) -51.78500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Codexis Inc. revenues increased 51% to $27.6M. Net loss decreased 39% to $8.4M. Revenues reflect EMEA segment increase of 70% to $8.8M America segment increase of 56% to $9.7M. Lower net loss reflects Interest income increase from $67K to $245K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.31 to -$0.17.

 CDXSのテクニカル分析


 CDXSのニュース

   Codexis (CDXS) may be moving closer to profitability, after beating slowdown  2021/01/21 18:34:23 AlphaStreet
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to the virus crisis. The recent improvement in fiscal […] The post Codexis (CDXS) may be moving closer to profitability, after beating slowdown first appeared on AlphaStreet .
   Global Biocatalysis and Biocatalyst Suppliers Leadership & Benchmark Report 2020-2021 Featuring Dupont, Royal DSM N.V., Codexis Inc., BASF, AB Enzymes, Amano Enzymes, Novozymes A/S, and Chr. Hansen - ResearchAndMarkets.com  2021/01/07 08:23:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Leadership Quadrant of Biocatalysis and Biocatalyst Suppliers - 2021" report has been added to ResearchAndMarkets.com's offering. The biocatalysis and biocatalyst manufacture landscape is diverse and continually evolving. Major players in the the the the the biocatalysis and biocatalyst market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the biocatalysis and biocatalyst market extends b
   Why BlackRock Stock Will Continue to Rock  2021/01/01 00:31:00 Yahoo Finance
Organic growth and strong cash inflows should keep the company atop the asset-management pyramid. Also, Wall Street views on Codexis, IMAX, Alibaba, and Intel
   Codexis Announces Pricing of Public Offering of Common Stock - Stocks News Feed  2020/12/03 04:11:00 Stocks News Feed
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $17.50 per share. Net proceeds to Codexis from the offering are expected to be approximately $70.2… Read More »Codexis Announces Pricing of Public Offering of Common Stock
   Reviewing Codexis (NASDAQ:CDXS) & New Oriental Energy & Chemical (NASDAQ:NOEC)  2020/10/24 12:12:50 Dakota Financial News
Codexis (NASDAQ:CDXS) and New Oriental Energy & Chemical (OTCMKTS:NOEC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings & Valuation This table compares Codexis and New Oriental Energy & Chemical’s gross […]
   Codexis (CDXS) may be moving closer to profitability, after beating slowdown  2021/01/21 18:34:23 AlphaStreet
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to the virus crisis. The recent improvement in fiscal […] The post Codexis (CDXS) may be moving closer to profitability, after beating slowdown first appeared on AlphaStreet .
   Global Biocatalysis and Biocatalyst Suppliers Leadership & Benchmark Report 2020-2021 Featuring Dupont, Royal DSM N.V., Codexis Inc., BASF, AB Enzymes, Amano Enzymes, Novozymes A/S, and Chr. Hansen - ResearchAndMarkets.com  2021/01/07 08:23:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Leadership Quadrant of Biocatalysis and Biocatalyst Suppliers - 2021" report has been added to ResearchAndMarkets.com's offering. The biocatalysis and biocatalyst manufacture landscape is diverse and continually evolving. Major players in the the the the the biocatalysis and biocatalyst market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the biocatalysis and biocatalyst market extends b
   Why BlackRock Stock Will Continue to Rock  2021/01/01 00:31:00 Yahoo Finance
Organic growth and strong cash inflows should keep the company atop the asset-management pyramid. Also, Wall Street views on Codexis, IMAX, Alibaba, and Intel
   Codexis Announces Pricing of Public Offering of Common Stock - Stocks News Feed  2020/12/03 04:11:00 Stocks News Feed
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $17.50 per share. Net proceeds to Codexis from the offering are expected to be approximately $70.2… Read More »Codexis Announces Pricing of Public Offering of Common Stock
   Reviewing Codexis (NASDAQ:CDXS) & New Oriental Energy & Chemical (NASDAQ:NOEC)  2020/10/24 12:12:50 Dakota Financial News
Codexis (NASDAQ:CDXS) and New Oriental Energy & Chemical (OTCMKTS:NOEC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings & Valuation This table compares Codexis and New Oriental Energy & Chemical’s gross […]
   Codexis Announces Pricing of Public Offering of Common Stock - Stocks News Feed  2020/12/03 04:11:00 Stocks News Feed
REDWOOD CITY, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading protein engineering company, today announced the pricing of an underwritten public offering of 4,285,715 shares of its common stock at a public offering price of $17.50 per share. Net proceeds to Codexis from the offering are expected to be approximately $70.2… Read More »Codexis Announces Pricing of Public Offering of Common Stock
   Reviewing Codexis (NASDAQ:CDXS) & New Oriental Energy & Chemical (NASDAQ:NOEC)  2020/10/24 12:12:50 Dakota Financial News
Codexis (NASDAQ:CDXS) and New Oriental Energy & Chemical (OTCMKTS:NOEC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Earnings & Valuation This table compares Codexis and New Oriental Energy & Chemical’s gross […]
   Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley Sells 2,500 Shares of Stock  2020/10/24 10:52:43 Zolmax News
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley sold 2,500 shares of the firm’s stock in a transaction on Wednesday, October 21st. The shares were sold at an average price of $14.00, for a total transaction of $35,000.00. Following the completion of the transaction, the director now directly owns 211,136 shares of the company’s stock, valued […]
   Insider Selling: Codexis, Inc. (NASDAQ:CDXS) Director Sells 2,500 Shares of Stock  2020/10/23 16:52:48 US Banking News
Codexis, Inc. (NASDAQ:CDXS) Director Bernard J. Kelley sold 2,500 shares of the business’s stock in a transaction on Wednesday, October 21st. The shares were sold at an average price of $14.00, for a total value of $35,000.00. Following the completion of the sale, the director now owns 211,136 shares of the company’s stock, valued at […]
   Codexis, Inc. (NASDAQ:CDXS) Receives Consensus Rating of “Buy” from Analysts  2020/10/23 11:14:47 Zolmax News
Shares of Codexis, Inc. (NASDAQ:CDXS) have received an average recommendation of “Buy” from the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The average […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 コデクシス CDXS Codexis Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)